Peripheral Arterial Disease Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The patient must be a child or young person between 0 and 18 years old who is scheduled for a planned (non-emergency) same-day surgery or a procedure that requires anesthesia outside of an operating room
- The patient must need a drip or IV line placed into a vein
- A parent or legal guardian must be available and willing to sign a consent form giving permission for the child to take part
- The patient must be suitable for having their vein found and accessed with the help of an imaging device
Who may not be able to join:
- Children who need emergency or urgent surgery or treatment cannot take part
- Children whose parent or legal guardian is unable to give written consent cannot take part
- Children who have a problem with their arm or leg (such as an infection, swelling, or wound) that would make it impossible to place an IV line in that area cannot take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sibel Seckin Pehlivan, Department of Anaesthesiology and Reanimation, Erciyes University, Kayseri, Turkey
Phone: 0905052532919
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The time to establish peripheral vascular access; number of attempts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.